THE SCHEDULE 13D

Company

Forte Biosciences, Inc.

Filed

July 5, 2022

Accession Number

0000921895-22-002146

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →